Why Lantheus Shares Falter Amid Rising R&D Costs and Market Competition
Investors spot Lantheus’s slide: below its 200‑day SMA, high P/E, rising R&D costs and stiff competition risk a continued undervaluation.
3 minutes to read
LANTHEUS HOLDINGS INC